Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Vanessa Cristina Gonçalves dos Santos, Marco Tadeu Grassi & Gilberto Abate. (2015) Speciation of Antimony(III) and Antimony(V) in Bottled Water by Hydride Generation-Inductively Coupled Plasma Optical Emission Spectrometry. Analytical Letters 48:18, pages 2921-2935.
Read now
Read now
Manu Vanaerschot, Saskia Decuypere, Maya Berg, Syamal Roy & Jean-Claude Dujardin. (2013) Drug-resistant microorganisms with a higher fitness – can medicines boost pathogens?. Critical Reviews in Microbiology 39:4, pages 384-394.
Read now
Read now
P. Collini, N. Premchand, D. Lockwood & J. Greig. (2009) Successful use of miltefosine and sodium stibogluconate, in combination, for the treatment of an HIV-positive patient with visceral leishmaniasis: a case report and brief review of the literature. Annals of Tropical Medicine & Parasitology 103:5, pages 455-459.
Read now
Read now
Jesús Troya, Angela Casquero, Elena Refoyo, Manuel L. Fernández-Guerrero & Miguel Górgolas. (2008) Long term failure of miltefosine in the treatment of refractory visceral leishmaniasis in AIDS patients. Scandinavian Journal of Infectious Diseases 40:1, pages 78-80.
Read now
Read now
K. Pandey, P. K. Sinha, V. N. R. Das, N. Kumar, S. M. Hassan, N. Verma, C. S. Lal, S. Bimal, P. Das & S. K. Bhattacharya. (2005) HIV-1 infection, visceral leishmaniasis, Koch's chest and tuberculous meningitis in the same patient — a case report. Annals of Tropical Medicine & Parasitology 99:8, pages 807-811.
Read now
Read now
A. Nandy, M. Addy, A.K. Maji & S.K. Guha. (2004) Impact of a co-factor on the dynamics of Leishmania donovani infection: does HIV infection encourage the recurrence of visceral leishmaniasis following post-kala-azar dermal leishmaniasis?. Annals of Tropical Medicine & Parasitology 98:6, pages 651-654.
Read now
Read now
C. Chicharro & J. Alvar. (2003) Lower trypanosomatids in HIV/AIDS patients. Annals of Tropical Medicine & Parasitology 97:sup1, pages 75-78.
Read now
Read now
Articles from other publishers (45)
Carolyn A. Tylenda, Francisco A. Tomei Torres & Dexter W. SullivanJr.Jr.. 2022. Handbook on the Toxicology of Metals. Handbook on the Toxicology of Metals
23
40
.
Shobha Upreti, Veni Pande, Diksha Joshi, Vinita Gouri & Mukesh Samant. 2021. Pathogenesis, Treatment and Prevention of Leishmaniasis. Pathogenesis, Treatment and Prevention of Leishmaniasis
209
229
.
Nahid Maspi, Fatemeh Ghaffarifar, Zohreh Sharifi, Abdolhossein Dalimi & Mohammad Saaid Dayer. (2017) Comparative Assessment of Induced Immune Responses Following Intramuscular Immunization with Fusion and Cocktail of LeIF, LACK and TSA Genes Against Cutaneous Leishmaniasis in BALB/c Mice. Archivum Immunologiae et Therapiae Experimentalis 66:1, pages 55-64.
Crossref
Crossref
Wim Adriaensen, Thomas P. C. Dorlo, Guido Vanham, Luc Kestens, Paul M. Kaye & Johan van Griensven. (2018) Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients. Frontiers in Immunology 8.
Crossref
Crossref
Emily E. Evans & Mark J. Siedner. (2017) Tropical Parasitic Infections in Individuals Infected With HIV. Current Tropical Medicine Reports 4:4, pages 268-280.
Crossref
Crossref
Graça Maria de Castro Viana, Marcos Antonio Custódio Neto da Silva, João Victor de Sousa Garcia, Helaine Dias Guimarães, Gelson Farias Arcos Júnior, Augusto Viana Arouche Santos, Pedro Viana da Paixão, Maria do Desterro Soares Brandão Nascimento & Carolina de Souza Galvão. (2017) Epidemiological profile of patients co-infected with visceral leishmaniasis and HIV/AIDS in Northeast, Brazil. Revista da Sociedade Brasileira de Medicina Tropical 50:5, pages 613-620.
Crossref
Crossref
Forough Khadem, Ping Jia, Zhirong Mou, Aida Feiz Barazandeh, Dong Liu, Yoav Keynan & Jude E. Uzonna. (2017) Pharmacological inhibition of p110δ subunit of PI3K confers protection against experimental leishmaniasis. Journal of Antimicrobial Chemotherapy 72:2, pages 467-477.
Crossref
Crossref
Naomi Aronson, Barbara L Herwaldt, Michael Libman, Richard Pearson, Rogelio Lopez-Velez, Peter Weina, Edgar M Carvalho, Moshe Ephros, Selma Jeronimo & Alan Magill. (2016) Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clinical Infectious Diseases 63:12, pages e202-e264.
Crossref
Crossref
N. Hussaini, J. M-S Lubuma, K. Barley & A.B. Gumel. (2016) Mathematical analysis of a model for AVL–HIV co-endemicity. Mathematical Biosciences 271, pages 80-95.
Crossref
Crossref
Priyodarshi Sengupta, Mainuddin Naskar, Raj Gupta, Nandita Bose, Sushanta Banerjee & Niranjan Bhattacharya. 2016. Human Fetal Growth and Development. Human Fetal Growth and Development
415
440
.
Carolyn A. Tylenda, Dexter W. SullivanJr.Jr. & Bruce A. Fowler. 2015. Handbook on the Toxicology of Metals. Handbook on the Toxicology of Metals
565
579
.
Stephanie D. Kruchten, Kristina M. Bacon & Bruce Y. Lee. (2014) The Impact of Human Immunodeficiency Virus (HIV) Co-Infection on the Economic Burden of Cutaneous Leishmaniasis (CL) in Brazil and Potential Value of New CL Drug Treatments. The American Journal of Tropical Medicine and Hygiene 91:3, pages 520-527.
Crossref
Crossref
Reza Shafiei, Mehdi Mohebali, Behnaz Akhoundi, Meysam Sharifdini Galian, Fathollah Kalantar, Saeedeh Ashkan, Abdolmajid Fata, Bibi Razieh Hosseini Farash & Mehrdad Ghasemian. (2014) Emergence of co-infection of visceral leishmaniasis in HIV-positive patients in northeast Iran: A preliminary study. Travel Medicine and Infectious Disease 12:2, pages 173-178.
Crossref
Crossref
Saovanee Leelayoova, Seksit Osatakul, Atitaya Hitakarun, Rommanee Kositnitikul, Mathirut Mungthin, Suradej Siripattanapipong & Tawee Naaglor. (2014) Recurrences of Visceral Leishmaniasis Caused by Leishmania siamensis after Treatment with Amphotericin B in a Seronegative Child. The American Journal of Tropical Medicine and Hygiene 90:1, pages 40-42.
Crossref
Crossref
Francesco Di Masi, Tamara Ursini, Maria Donata Iannece, Leonardo Chianura, Francesco Baldasso, Giuseppe Foti, Pietro Di Gregorio, Angelo Casabianca, Nunzio Storaci, Luciano Nigro, Claudia Colomba, Maria Grazia Marazzi, Giovanni Todaro, Giacinta Tordini, Giacomo Zanelli, Giovanni Cenderello, Nicola Acone, Ennio Polilli, Simona Migliore, Paolo Almi, Eligio Pizzigallo, Evangelista Sagnelli, Francesco Mazzotta, Rosario Russo, Lamberto Manzoli & Giustino Parruti. (2014) Five-Year Retrospective Italian Multicenter Study of Visceral Leishmaniasis Treatment. Antimicrobial Agents and Chemotherapy 58:1, pages 414-418.
Crossref
Crossref
Gouri Sankar Bhunia, Shreekant Kesari, Nandini Chatterjee, Vijay Kumar & Pradeep Das. (2013) The Burden of Visceral Leishmaniasis in India: Challenges in Using Remote Sensing and GIS to Understand and Control. ISRN Infectious Diseases 2013, pages 1-14.
Crossref
Crossref
Gláucia F. Cota, Marcos R. de Sousa, Tatiani Oliveira Fereguetti & Ana Rabello. (2013) Efficacy of Anti-Leishmania Therapy in Visceral Leishmaniasis among HIV Infected Patients: A Systematic Review with Indirect Comparison. PLoS Neglected Tropical Diseases 7:5, pages e2195.
Crossref
Crossref
Louis Maes, Raquel Andreia Inocencio da Luz, Paul Cos & Vanessa Yardley. 2013. Drug Resistance in Leishmania Parasites. Drug Resistance in Leishmania Parasites
301
319
.
K. Ritmeijer, R. ter Horst, S. Chane, E. M. Aderie, T. Piening, S. M. Collin & R. N. Davidson. (2011) Limited Effectiveness of High-Dose Liposomal Amphotericin B (AmBisome) for Treatment of Visceral Leishmaniasis in an Ethiopian Population With High HIV Prevalence. Clinical Infectious Diseases 53:12, pages e152-e158.
Crossref
Crossref
P. K. Sinha, J. van Griensven, K. Pandey, N. Kumar, N. Verma, R. Mahajan, P. Kumar, R. Kumar, P. Das, G. Mitra, L. Flevaud, C. Ferreyra, D. Remartinez, M. Pece & P. P. Palma. (2011) Liposomal Amphotericin B for Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients: 2-Year Treatment Outcomes in Bihar, India. Clinical Infectious Diseases 53:7, pages e91-e98.
Crossref
Crossref
BJ Angus, ML Schmid, DH Dockrell & AD Grant. (2011) 10 Travel-related opportunistic infections. HIV Medicine 12, pages 88-101.
Crossref
Crossref
Elisangela de Oliveira, Elisa Teruya Oshiro, Rebeca Vieira Pinto, Bruna Corrêa de Castro, Karla Borges Daniel, Janaina Michelle de Oliveira, Manoel Sebastião da Costa Lima Júnior, Euripedes Batista Guimarães, Jesiel Mamedes Silva & Maria Elizabeth Cavalheiros Dorval. (2011) Presence of amastigotes in the central nervous system of hamsters infected with Leishmania sp.. Revista Brasileira de Parasitologia Veterinária 20:2, pages 97-102.
Crossref
Crossref
Pierre A. Buffet, Éric Rosenthal, Jean-Pierre Gangneux, Edward Lightburne, Pierre Couppié, Gloria Morizot, Laurence Lachaud, Pierre Marty & Jean-Pierre Dedet. (2011) Traitement des leishmanioses en France : proposition d’un référentiel consensuel. La Presse Médicale 40:2, pages 173-184.
Crossref
Crossref
Priscilla Alexandrino-de-Oliveira, Joanna Reis Santos-Oliveira, Maria Elizabeth Cavalheiros Dorval, Francisco das Chagas Brandão Da-Costa, Gracy Regina Oliveira Leite Pereira, Rivaldo Venâncio da Cunha, Anamaria Mello Miranda Paniago & Alda Maria Da-Cruz. (2010) HIV/AIDS-associated visceral leishmaniasis in patients from an endemic area in Central-west Brazil. Memórias do Instituto Oswaldo Cruz 105:5, pages 692-697.
Crossref
Crossref
Jan Rybniker, Valentin Goede, Jessica Mertens, Monika Ortmann, Wolfgang Kulas, Matthias Kochanek, Thomas Benzing, José R. Arribas & Gerd Fätkenheuer. (2010) Treatment of visceral leishmaniasis with intravenous pentamidine and oral fluconazole in an HIV-positive patient with chronic renal failure — a case report and brief review of the literature. International Journal of Infectious Diseases 14:6, pages e522-e525.
Crossref
Crossref
E. Rosenthal, P. Delaunay, P.-Y. Jeandel, H. Haas, C. Pomares-Estran & P. Marty. (2009) Le traitement de la leishmaniose viscérale en Europe en 2009. Place de l’amphotéricine B liposomale. Médecine et Maladies Infectieuses 39:10, pages 741-744.
Crossref
Crossref
E. F. Daher, P. P. Fonseca, E. S. Gerhard, T. M. J. Silva Leitão & G. B. Silva Júnior. (2009) Clinical and Epidemiological Features of Visceral Leishmaniasis and Hiv Co-infection in Fifteen Patients from Brazil. Journal of Parasitology 95:3, pages 652-655.
Crossref
Crossref
E. Rosenthal & P. Marty. (2009) Actualités sur la leishmaniose viscérale méditerranéenne. La Revue de Médecine Interne 30, pages S24-S28.
Crossref
Crossref
JAMES O. LLOYD-SMITH, MARY POSS & BRYAN T. GRENFELL. (2008) HIV-1/parasite co-infection and the emergence of new parasite strains. Parasitology 135:7, pages 795-806.
Crossref
Crossref
Jorge Alvar, Pilar Aparicio, Abraham Aseffa, Margriet Den Boer, Carmen Cañavate, Jean-Pierre Dedet, Luigi Gradoni, Rachel Ter Horst, Rogelio López-Vélez & Javier Moreno. (2008) The Relationship between Leishmaniasis and AIDS: the Second 10 Years. Clinical Microbiology Reviews 21:2, pages 334-359.
Crossref
Crossref
Elsa Briones, Clara Isabel Colino & José M. Lanao. (2008) Delivery systems to increase the selectivity of antibiotics in phagocytic cells. Journal of Controlled Release 125:3, pages 210-227.
Crossref
Crossref
Eduardo Ortega-Barria & Luz I. Romero. 2008. Principles and Practice of Pediatric Infectious Disease. Principles and Practice of Pediatric Infectious Disease
1246
1253
.
Emanuela Handman, Lukasz Kedzierski, Alessandro D. Uboldi & James W. Goding. 2008. Drug Targets in Kinetoplastid Parasites. Drug Targets in Kinetoplastid Parasites
48
60
.
V. Vanlerberghe, G. Diap, P. J. Guerin, F. Meheus, S. Gerstl, P. Van der Stuyft & M. Boelaert. (2007) Drug policy for visceral leishmaniasis: a cost-effectiveness analysis. Tropical Medicine & International Health 12:2, pages 274-283.
Crossref
Crossref
CAROLYN A. TYLENDA & BRUCE A. FOWLER. 2007. Handbook on the Toxicology of Metals. Handbook on the Toxicology of Metals
353
365
.
Carlos Pérez, Yoanet Solías & Gerzaín Rodríguez. (2006) Leishmaniasis cutánea difusa en un paciente con sida. Biomédica 26:4, pages 485.
Crossref
Crossref
Caryn Bern, Jill Adler‐Moore, Juan Berenguer, Marleen Boelaert, Margriet den Boer, Robert N. Davidson, Concepcion Figueras, Luigi Gradoni, Dimitris A. Kafetzis, Koert Ritmeijer, Eric Rosenthal, Catherine Royce, Rosario Russo, Shyam Sundar & Jorge Alvar. (2006) Reviews Of Anti‐infective Agents: Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis. Clinical Infectious Diseases 43:7, pages 917-924.
Crossref
Crossref
Gaetano BrindicciClaudia PicciarelliLuciana FumarolaSergio CarbonaraFrancesca StanoEmanuela CiracìMarina GramicciaAnna Rosa SannellaMichele MilellaDanila De VitoRosa MonnoLaura Monno. (2006) Amoebic Hepatic Abscesses in an HIV-Positive Patient. AIDS Patient Care and STDs 20:9, pages 606-611.
Crossref
Crossref
David R. Snydman, Melanie Walker, James G. Kublin & Joseph R. Zunt. (2006) Parasitic Central Nervous System Infections in Immunocompromised Hosts: Malaria, Microsporidiosis, Leishmaniasis, and African Trypanosomiasis. Clinical Infectious Diseases 42:1, pages 115-125.
Crossref
Crossref
Henry W Murray, Jonathan D Berman, Clive R Davies & Nancy G Saravia. (2005) Advances in leishmaniasis. The Lancet 366:9496, pages 1561-1577.
Crossref
Crossref
C. Schraner, B. Hasse, U. Hasse, D. Baumann, A. Faeh, G. Burg, F. Grimm, A. Mathis, R. Weber & H. F. Gunthard. (2005) Successful Treatment with Miltefosine of Disseminated Cutaneous Leishmaniasis in a Severely Immunocompromised Patient Infected with HIV-1. Clinical Infectious Diseases 40:12, pages e120-e124.
Crossref
Crossref
F. Pasquau, J. Ena, R. Sanchez, J. M. Cuadrado, C. Amador, J. Flores, C. Benito, C. Redondo, J. Lacruz, V. Abril & J. Onofre. (2005) Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region. European Journal of Clinical Microbiology & Infectious Diseases 24:6, pages 411-418.
Crossref
Crossref
Abhijit M Bal. (2005) Visceral leishmaniasis—an opportunistic infection in HIV-infected patients. The Lancet Infectious Diseases 5:4, pages 196-197.
Crossref
Crossref
H. Sindermann, K. R. Engel, C. Fischer & W. Bommer. (2004) Oral Miltefosine for Leishmaniasis in Immunocompromised Patients: Compassionate Use in 39 Patients with HIV Infection. Clinical Infectious Diseases 39:10, pages 1520-1523.
Crossref
Crossref
Susan Wyllie, Mark L. Cunningham & Alan H. Fairlamb. (2004) Dual Action of Antimonial Drugs on Thiol Redox Metabolism in the Human Pathogen Leishmania donovani. Journal of Biological Chemistry 279:38, pages 39925-39932.
Crossref
Crossref